Oxford-ZEISS advances breakthrough live-cell imaging platform for next-gen drug discovery
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
The goal is to better support drug developers as programs move from laboratory research into clinical trials
To boost compostable packaging, resin innovation, and supply chain speed
Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Move amid evidence of widespread reporting gaps
Subscribe To Our Newsletter & Stay Updated